Xylazine can cause severe skin wounds, but whether it is leading to more deaths is not yet clear.
opioid epidemic
Maine will receive at least $235 million in settlements from companies accused of fueling the opioid crisis
A Maine Monitor analysis looks at who stands to benefit from this money and why it matters.
Maine House narrowly supports bill that would allow safe drug consumption sites
Thursday’s 77-66 vote followed emotional testimony on both sides. The measure now goes to the Senate.
Mills announces plan to add 140 treatment beds to combat ongoing opioid crisis
The $6 million investment is the latest effort to reverse an epidemic that claimed a record 716 lives just last year.
‘Keep them alive’: More states legalize fentanyl test strips to combat surging opioid deaths
A growing number of states are decriminalizing fentanyl testing strips, seeking to protect people who use drugs from unwitting exposure to the highly potent synthetic opioid ravaging the U.S. with overdose deaths.
Pills flowed for years as DEA dragged feet on disciplining opioid distributor
The delay has raised concerns about how the revolving door between government and industry may be impacting the DEA’s mission to police drug companies blamed for tens of thousands of American overdose deaths.
Falmouth Police recovery coach program assists 140 people so far
The program, which has received a grant to continue, lines up resources for those who seek help for substance misuse.
Quiet and parents’ touch help opioid users’ newborns, study finds
Babies born to opioid users, including mothers in treatment with medications such as methadone, can develop withdrawal symptoms after exposure in the womb.
Overdose deaths of older Americans quadrupled in past 20 years
Older adults are often prescribed opioids to help them cope with chronic pain or recover from a surgical procedure.
FDA approves over-the-counter Narcan. Here’s what it means.
The U.S. Food and Drug Administration has approved over-the-counter sales of the overdose antidote naloxone, marking the first time an opioid treatment drug will be available without a prescription.